The article "Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression" by Lucas Fornari Laurindo et al. reviews the immunological aspects of neuroinflammation and microglial activation, focusing on age-related neurodegenerative conditions. The authors highlight the role of microglia and astrocytes in releasing pro-inflammatory cytokines and chemokines, leading to neuronal damage and neurodegeneration through pathways like NLRP3 and NF-κB activation, and decreased Nrf2 activity. They discuss the limitations of conventional drugs in inhibiting neuroinflammatory targets and explore innovative immunomodulatory therapies, including Interleukin-Driven Immunomodulation, Chemokine (CXC) Receptor Signaling and Expression, Cold Exposure, and Fibrin-Targeted strategies, which show promise in mitigating neuroinflammatory processes. The review also emphasizes the need for randomized clinical trials to evaluate the safety and efficacy of these therapies. Additionally, the article delves into the mechanisms of NF-κB, NLRP3 inflammasome, and Nrf2 in neuroinflammation, providing a comprehensive overview of their roles and potential therapeutic applications.The article "Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression" by Lucas Fornari Laurindo et al. reviews the immunological aspects of neuroinflammation and microglial activation, focusing on age-related neurodegenerative conditions. The authors highlight the role of microglia and astrocytes in releasing pro-inflammatory cytokines and chemokines, leading to neuronal damage and neurodegeneration through pathways like NLRP3 and NF-κB activation, and decreased Nrf2 activity. They discuss the limitations of conventional drugs in inhibiting neuroinflammatory targets and explore innovative immunomodulatory therapies, including Interleukin-Driven Immunomodulation, Chemokine (CXC) Receptor Signaling and Expression, Cold Exposure, and Fibrin-Targeted strategies, which show promise in mitigating neuroinflammatory processes. The review also emphasizes the need for randomized clinical trials to evaluate the safety and efficacy of these therapies. Additionally, the article delves into the mechanisms of NF-κB, NLRP3 inflammasome, and Nrf2 in neuroinflammation, providing a comprehensive overview of their roles and potential therapeutic applications.